What is in Wegovy and How Can It Help You?

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA in 2021 for chronic weight management. This medication works by activating receptors in your brain and digestive system that regulate appetite, leading to sustained weight loss for many patients. PlexusDx provides access to compounded semaglutide injections from licensed 503A pharmacies, offering the same active ingredient at a lower cost.

The Active Ingredient: Understanding Semaglutide

Semaglutide is a synthetic version of GLP-1, a hormone your body naturally produces in response to eating. When you take semaglutide, it binds to GLP-1 receptors throughout your brain and gut, sending signals that you feel fuller longer and have less desire to eat. Clinical trials show that patients using semaglutide lose an average of 15–22% of their body weight over 68 weeks when combined with lifestyle changes.

The medication also slows gastric emptying, meaning food stays in your stomach longer, which contributes to prolonged satiety. Beyond weight loss, semaglutide can help improve blood sugar control and reduce cardiovascular risk in people with type 2 diabetes. PlexusDx sources semaglutide from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality without the brand-name markup.

How Semaglutide Works in Your Body

Semaglutide enters your bloodstream through a weekly subcutaneous injection, typically given in the abdomen, thigh, or upper arm. Once absorbed, it circulates for approximately 7 days, which is why dosing is once per week rather than daily. The medication's effects are cumulative; many patients notice reduced appetite and increased fullness within the first 2–3 weeks of starting treatment.

The drug works on multiple appetite-control pathways in your hypothalamus and brainstem, the regions of your brain that regulate hunger and energy expenditure. It also improves insulin secretion in response to meals, helping stabilize blood sugar and reduce cravings for high-calorie foods. These dual mechanisms explain why semaglutide is so effective for weight loss compared to diet and exercise alone.

Key Active Compounds and Their Effects

Semaglutide contains no fillers, dyes, or inactive ingredients that directly affect appetite suppression—the active pharmaceutical itself is the entire mechanism. Each injection delivers a precisely measured dose of the semaglutide molecule, which your body metabolizes and gradually eliminates over the week. PlexusDx compounded semaglutide maintains the same concentration and purity as brand Wegovy, with your dose adjusted based on your individual response and tolerance.

Beyond the active semaglutide compound, PlexusDx offers the Precision Peptide Genetic Test, which identifies genetic variants in key appetite-regulation pathways like GLP1R (rs6923761), GIPR (rs1800437), and FTO (rs9939609). Understanding your genetic predispositions can help determine whether you're a strong responder to semaglutide or might benefit from dual-compound therapies like GLP-Squared, which combines semaglutide with tirzepatide.

Why Choose Compounded Semaglutide Over Brand Wegovy

Brand Wegovy can cost $900–$1,350 per month without insurance coverage, making it inaccessible for many patients seeking weight loss support. PlexusDx compounded semaglutide injections start at just $189/mo (or $149/mo on the 6-month plan)—the same active ingredient, sourced from licensed 503A compounding pharmacies, with no insurance required and no membership fees. Your dose may need to go up. Your price won't.

Compounded semaglutide undergoes the same quality standards and sterility testing as brand medications and is FDA-regulated as a compounded pharmaceutical. PlexusDx serves all 50 states and accepts HSA and FSA accounts for additional savings. Patients can begin treatment within days and adjust their dose as needed without worry about escalating costs, making semaglutide therapy sustainable long-term.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What exactly is in a Wegovy injection?

Wegovy contains semaglutide, a GLP-1 receptor agonist, dissolved in a sterile solution with sodium chloride and other pharmaceutical-grade stabilizers. PlexusDx compounded semaglutide has the same active ingredient and formulation quality as brand Wegovy, available from licensed 503A pharmacies starting at $149 per month.

How much weight can I expect to lose with semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Is compounded semaglutide from PlexusDx safe and effective?

Yes. PlexusDx sources compounded semaglutide exclusively from licensed 503A compounding pharmacies, which are FDA-regulated and meet strict quality and sterility standards. The active ingredient and clinical effects are identical to brand Wegovy, with the same safety profile when used as directed.

What are the common side effects of semaglutide?

Most common side effects include nausea, vomiting, and diarrhea, typically mild and temporary as your body adjusts. Serious side effects are rare but can include pancreatitis or gallbladder issues; inform your PlexusDx provider of any family history of thyroid cancer or multiple endocrine neoplasia. Your provider monitors your tolerance and adjusts your dose accordingly.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The Precision Peptide Genetic Test ($99 after your first month of treatment) maps 14 appetite and metabolism pathways, including GLP1R and GIPR variants, helping identify whether you're a strong genetic responder to semaglutide or might benefit from dual-compound therapy like GLP-Squared. This personalization improves treatment outcomes.

Related Reading

• What Is Genetic Peptide Testing And Why It Matters Before You Start A Protocol
• What Causes Flatulence And How Can You Control It Effectively
• What Are The Causes Of Hip Pain And How Can You Manage It Effectively
• Can You Avoid Diabetes If It Runs In Your Family

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.